{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:13:34Z","timestamp":1790028814305,"version":"4.0.1"},"reference-count":85,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cochrane Complementary Medicine bursary award","award":["for the year 2015"],"award-info":[{"award-number":["for the year 2015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Cardiovascular disease (CVD) is the leading cause of death globally and hypercholesterolemia is one of the major risk factors associated with CVD. Due to a growing body of research on side effects and long-term impacts of conventional CVD treatments, focus is shifting towards exploring alternative treatment approaches such as Ayurveda. However, because of a lack of strong scientific evidence, the safety and efficacy profiles of such interventions have not been well established. The current study aims to conduct a systematic review and meta-analyses to explore the strength of evidence on efficacy and safety of Ayurvedic herbs for hypercholesterolemia. Methods: Literature searches were conducted using databases including Medline, Cochrane Database, AMED, Embase, AYUSH research portal, and many others. All randomized controlled trials on individuals with hypercholesterolemia using Ayurvedic herbs (alone or in combination) with an exposure period of \u2265 3 weeks were included, with primary outcomes being total cholesterol levels, adverse events, and other cardiovascular events. The search strategy was determined with the help of the Cochrane Metabolic and Endocrine Disorders Group. Two researchers assessed the risk of each study individually and discrepancies were resolved by consensus or consultation with a third researcher. Meta-analysis was conducted using the inverse variance method and results are presented as forest plots and data summary tables using Revman v5.3. Results: A systematic review of 32 studies with 1386 participants found randomized controlled trials of three Ayurvedic herbs, Allium sativum (garlic), Commiphora mukul (guggulu), and Nigella sativa (black cumin) on hypercholesterolemia that met inclusion criteria. The average duration of intervention was 12 weeks. Meta-analysis of the trials showed that guggulu reduced total cholesterol and low-density lipoprotein levels by 16.78 mg\/dL (95% C.I. 13.96 to 2.61; p-value = 0.02) and 18.78 mg\/dL (95% C.I. 34.07 to 3.48; p = 0.02), respectively. Garlic reduced LDL-C by 10.37 mg\/dL (95% C.I. \u221217.58 to \u22123.16; p-value = 0.005). Black cumin lowered total cholesterol by 9.28 mg\/dL (95% C.I. \u221217.36, to \u22121.19, p-value = 0.02). Reported adverse side effects were minimal. Conclusion: There is moderate to high level of evidence from randomized controlled trials that the Ayurvedic herbs guggulu, garlic, and black cumin are moderately effective for reducing hypercholesterolemia. In addition, minimal evidence was found for any side effects associated with these herbs, positioning them as safe adjuvants to conventional treatments.<\/jats:p>","DOI":"10.3390\/medicina57060546","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T01:51:37Z","timestamp":1622425897000},"page":"546","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Systematic Review and Meta-Analysis of Ayurvedic Herbal Preparations for Hypercholesterolemia"],"prefix":"10.3390","volume":"57","author":[{"given":"Dinesh","family":"Gyawali","sequence":"first","affiliation":[{"name":"College of Integrative Medicine, Maharishi International University, Fairfield, IA 52557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rini","family":"Vohra","sequence":"additional","affiliation":[{"name":"School of Science of Consciousness, Maharishi University of Information Technology, Noida 201304, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Orme-Johnson","sequence":"additional","affiliation":[{"name":"Maharishi International University, Fairfield, IA 52557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Ramaratnam","sequence":"additional","affiliation":[{"name":"Apollo Hospital, Greams Lane, Chennai, Tamil Nadu 600006, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Schneider","sequence":"additional","affiliation":[{"name":"College of Integrative Medicine, Maharishi International University, Fairfield, IA 52557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"ref_1","unstructured":"Mendis, S., Puska, P., and Norrving, B. (2011). Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2011). Vital signs: Prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol-United States, 1999\u20132002 and 2005\u20132008. MMWR, 4, 109\u2013114."},{"key":"ref_3","first-page":"81","article-title":"Hyperlipidemia: An updated review","volume":"1","author":"Gupta","year":"2011","journal-title":"Int. J. Biopharm. Toxicol. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) (2002). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106, 3143.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"(1984). The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA, 251, 351\u2013364.","DOI":"10.1001\/jama.251.3.351"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"(1984). The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. JAMA, 251, 365\u2013374.","DOI":"10.1001\/jama.251.3.365"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/clc.22428","article-title":"Burden of First and Recurrent Cardiovascular Events among Patients with Hyperlipidemia","volume":"38","author":"Punekar","year":"2015","journal-title":"Clin. Cardiol."},{"key":"ref_8","first-page":"303","article-title":"Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system","volume":"62","author":"Bahia","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_9","unstructured":"Soni, A. (2020, November 10). Top 10 Most Costly Conditions among Men and Women, 2008: Estimates for the U.S. Civilian Noninstitutionalized Adult Population, Age 18 and Older, Med. Expend. Panel Surv. (2011) Statistical Brief #331), Available online: https:\/\/meps.ahrq.gov\/data_files\/publications\/st331\/stat331.shtml."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCULATIONAHA.105.539106","article-title":"Treatment of Elevated Cholesterol","volume":"111","author":"Scirica","year":"2005","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin Adverse Effects","volume":"8","author":"Golomb","year":"2008","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/00325481.2017.1292107","article-title":"New onset diabetes mellitus induced by statins: Current evidence","volume":"129","author":"Chrysant","year":"2017","journal-title":"Postgrad. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14728214.2019.1591372","article-title":"Emerging drugs for the treatment of hypercholesterolemia","volume":"24","author":"Bove","year":"2019","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1161\/CIRCULATIONAHA.105.549857","article-title":"Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey","volume":"112","author":"Arnett","year":"2005","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/215731","article-title":"Role of Complementary and Alternative Medicine in Controlling Dyslipidemia","volume":"2014","author":"Qidwai","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_16","first-page":"22","article-title":"Ayurvedic and collateral herbal treatments for hyperlipidemia: A systematic review of randomized controlled trials and qua-si-experimental designs","volume":"13","author":"Singh","year":"2007","journal-title":"Altern. Ther. Health Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1878-5085-5-19","article-title":"Bridging Ayurveda with evidence-based scientific approaches in medicine","volume":"5","author":"Patwardhan","year":"2014","journal-title":"EPMA J."},{"key":"ref_18","first-page":"1","article-title":"Ayurveda: Between Religion, Spirituality, and Medicine","volume":"2013","author":"Kessler","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_19","first-page":"231","article-title":"Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: A randomised placebo-controlled trial","volume":"49","author":"Gupta","year":"2001","journal-title":"J. Assoc. Physicians India"},{"key":"ref_20","first-page":"39","article-title":"Garlic as a Lipid Lowering Agent\u2014A Meta-Analysis","volume":"28","author":"Silagy","year":"1994","journal-title":"J. R. Coll. Physicians Lond."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.290.6.765","article-title":"Guggulipid for the Treatment of Hypercholesterolemia","volume":"290","author":"Szapary","year":"2003","journal-title":"JAMA"},{"key":"ref_22","first-page":"1","article-title":"Role of Complementary and Alternative Medicine in Cardiovascular Diseases","volume":"2013","author":"Qidwai","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_23","unstructured":"Patwardhan, K. (2019). Promoting evidence-base for Ayurveda. J. Ayurveda Integr. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jep.2007.08.003","article-title":"Terminalia arjuna Wight & Arn.\u2014A useful drug for cardiovascular disorders","volume":"114","author":"Dwivedi","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/943162","article-title":"Terminalia arjunain Chronic Stable Angina: Systematic Review and Meta-Analysis","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol. Res. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ctim.2005.08.003","article-title":"Guggul for hyperlipidemia: A review by the Natural Standard Research Collaboration","volume":"13","author":"Ulbricht","year":"2005","journal-title":"Complement. Ther. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2221-1691(13)60075-1","article-title":"A review on therapeutic potential of Nigella sativa: A miracle herb","volume":"3","author":"Ahmada","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., G\u00f8tzsche, P.C., Ioannidis, J.P.A., Clarke, M., Devereaux, P.J., Kleijnen, J., and Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med., 6.","DOI":"10.2427\/5768"},{"key":"ref_29","unstructured":"Higgins, J.P.T., and Green, S. (2020, December 01). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. Updated March 2011. The Cochrane Collaboration, 2001. Available online: www.cochrane-handbook.org."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gyawali, D., Schneider, R.H., Orme-Johnson, D.W., and Ramaratnam, S. (2016). Ayurvedic herbal preparations for hypercholesterolaemia. Cochrane Database Syst. Rev., 3.","DOI":"10.1002\/14651858.CD012076"},{"key":"ref_31","unstructured":"Deeks, J., and Higgins, J. (2021, May 20). Statistical algorithms in Review Manager 5. Available online: https:\/\/training.cochrane.org\/handbook\/statistical-methods-revman5."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J. R. Stat. Soc. Ser. A"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"ref_38","first-page":"1056","article-title":"To compare the effects of Terminalia Arjuna with Rosuvastatin on total cholesterol and low-density lipoprotein cholesterol","volume":"5","author":"Prakash","year":"2016","journal-title":"Int. J. Med. Dent. Sci."},{"key":"ref_39","first-page":"210","article-title":"The effects of 8-week Nigella sativa supplementation and aerobic training on lipid profile and VO2 max in sedentary overweight females","volume":"5","author":"Farzaneh","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"ref_40","first-page":"44","article-title":"A clinical comparative study of rasonadi leha with hridrogadi churna in coronary artery disease","volume":"1","author":"Rathi","year":"2013","journal-title":"Punarnav"},{"key":"ref_41","first-page":"63","article-title":"Effect of Tulsi (Ocimum sanctum Linn.) on clinical and biochemical parameters of metabolic syndrome","volume":"12","author":"Devra","year":"2012","journal-title":"J. Nat. Remed."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0031-1280474","article-title":"Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial","volume":"78","author":"Huseini","year":"2012","journal-title":"Planta Med."},{"key":"ref_43","first-page":"225","article-title":"Hypolipidemic Activity of Phyllanthus Emblica Linn (Amla) & Trigonella Foenum Graecum (Fenugreek) Combination In Hypercholesterolemic Subjects\u2013A Prospective, Randomised, Parallel, Open-Label, Positive Controlled Study","volume":"2","author":"Joseph","year":"2012","journal-title":"Asian J. Bio. Pharma. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5455\/medarh.2012.66.198-200","article-title":"Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: A randomized, placebo controlled clinical trial","volume":"66","author":"Sabzghabaee","year":"2012","journal-title":"Med. Arch."},{"key":"ref_45","first-page":"15","article-title":"Management of stable angina with lashunadi guggulu- an ayurvedic formulation","volume":"1","author":"Sharma","year":"2012","journal-title":"Ann. Ayurvedic. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-9-119","article-title":"The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease","volume":"9","author":"Sobenin","year":"2010","journal-title":"Lipids Health Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ctim.2008.07.001","article-title":"Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study","volume":"17","author":"Nohr","year":"2009","journal-title":"Complement. Ther. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/acm.2008.0367","article-title":"Effectiveness, safety, and tolerability of powdered nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: Results of a randomized, double-blind controlled trial","volume":"15","author":"Qidwai","year":"2009","journal-title":"J. Altern. Complement. Med."},{"key":"ref_49","first-page":"1280","article-title":"Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial","volume":"29","author":"Roozbeh","year":"2008","journal-title":"Saudi Med. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5551\/jat.E550","article-title":"Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study","volume":"15","author":"Sobenin","year":"2008","journal-title":"J. Ather. Thromb."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archinte.167.4.346","article-title":"Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia","volume":"167","author":"Gardner","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_52","first-page":"60","article-title":"Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus","volume":"17","author":"Ashraf","year":"2005","journal-title":"J. Ayub. Med. Coll. Abbottabad."},{"key":"ref_53","first-page":"1156","article-title":"The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man","volume":"87","author":"Tanamai","year":"2004","journal-title":"J. Med. Ass. Thailand"},{"key":"ref_54","first-page":"18","article-title":"Can garlic extract supplement lower blood pressure in hypercholesterolemic subjects?","volume":"33","author":"Satitvipawee","year":"2003","journal-title":"J. Public Health"},{"key":"ref_55","unstructured":"(2021, May 28). Double-Blind Comparative Clinical Trial of Abana and Simvastatin in Hyperlipidaemia. Available online: https:\/\/cdn.greensoft.mn\/uploads\/users\/1977\/files\/tsakhurtumur%20sudalga\/Abana%20sudalgaa.pdf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/07315724.2001.10719036","article-title":"Hypocholesterolemic effect of an enteric-coated garlic supplement","volume":"20","author":"Kannar","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0021-9150(00)00466-4","article-title":"The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults","volume":"154","author":"Gardner","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ajcn\/65.2.445","article-title":"Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men","volume":"65","author":"Adler","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_59","first-page":"20","article-title":"Evaluation of the effect of the indigenous herbal drug lashunadi guggulu in management of chronic stable Angina","volume":"1","author":"Awasthi","year":"1997","journal-title":"Aryavaidyan Xi"},{"key":"ref_60","first-page":"65","article-title":"Gugulipid, a new hypolipidaemic agent, in patients of acute ischaemic stroke: Effect on clinical outcome, platelet function and serum lipids","volume":"12","author":"Gaur","year":"1997","journal-title":"Asia Pacif. J. Pharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF00877420","article-title":"Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia","volume":"8","author":"Singh","year":"1994","journal-title":"Cardiovasc. Drugs. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9343(93)90216-C","article-title":"Can garlic reduce levels of serum lipids? A controlled clinical study","volume":"94","author":"Jain","year":"1993","journal-title":"Am. J. Med."},{"key":"ref_63","first-page":"14","article-title":"Perspective, randomised crossover study of propranolol and Abana in hypertensive patients: Effect on lipids and lipoproteins","volume":"88","author":"Tiwari","year":"1991","journal-title":"Antiseptic."},{"key":"ref_64","first-page":"1111","article-title":"Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners\u2019 multicentric placebo-controlled double-blind study","volume":"40","author":"Mader","year":"1990","journal-title":"Arzneimittel-Forschung"},{"key":"ref_65","first-page":"323","article-title":"Clinical trials with gugulipid. A new hypolipidaemic agent","volume":"37","author":"Nityanand","year":"1989","journal-title":"J. Assoc. Physicians Ind."},{"key":"ref_66","first-page":"356","article-title":"Effect of Commiphora mukul (gum guggulu) in patients of hyperlipidemia with special reference to HDL-cholesterol","volume":"87","author":"Verma","year":"1988","journal-title":"Indian J. Med. Res."},{"key":"ref_67","first-page":"20","article-title":"Gum guggulu (Commiphora mukul) fraction A in obesity\u2014A double-blind clinical trial","volume":"6","author":"Kotiyal","year":"1985","journal-title":"J. Res. Ayur. Siddha."},{"key":"ref_68","first-page":"367","article-title":"Effect of guggul (Commiphora mukul\u2013Engl.) on serum lipids in obese, hypercholesterolemic and hyperlipemic cases","volume":"26","author":"Kuppurajan","year":"1978","journal-title":"J. Assoc. Physicians India."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.308.6925.367","article-title":"By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?","volume":"308","author":"Law","year":"1994","journal-title":"BMJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2009.02.017","article-title":"The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis","volume":"31","author":"Delahoy","year":"2009","journal-title":"Clin. Ther."},{"key":"ref_71","unstructured":"Chunekar, K.C. (2009). Bhavprakash Nighantu of Bhavmisra, Chaukambha Orientalia."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.nutr.23.011702.073102","article-title":"GUGULIPID: A Natural Cholesterol-Lowering Agent","volume":"23","author":"Urizar","year":"2003","journal-title":"Annu. Rev. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/2047487314533085","article-title":"Misinterpretation of trial evidence on statin adverse effects may harm patients","volume":"22","author":"Golomb","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/nure.12012","article-title":"Effect of garlic on serum lipids: An updated meta-analysis","volume":"71","author":"Ried","year":"2013","journal-title":"Nutr. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0954422409350003","article-title":"The impact of garlic on lipid parameters: A systematic review and meta-analysis","volume":"22","author":"Reinhart","year":"2009","journal-title":"Nutr. Res. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1062-1458(00)00173-2","article-title":"Garlic for treating hypercholesterolemia","volume":"10","author":"Stevinson","year":"2001","journal-title":"ACC Curr. J. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"955S","DOI":"10.1093\/jn\/131.3.955S","article-title":"Intake of garlic and its bioactive components","volume":"131","author":"Amagase","year":"2001","journal-title":"J. Nutr."},{"key":"ref_78","unstructured":"Shastri, K. (2001). Sushruta Samhita of Maharshi Sushruta Part I, Chaukhamba Sanskrita Sansthana. [14th ed.]."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jch.12473","article-title":"Effect of Garlic on Blood Pressure: A Meta-Analysis","volume":"17","author":"Wang","year":"2015","journal-title":"J. Clin. Hypertens."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.phrs.2016.02.008","article-title":"Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"106","author":"Sahebkar","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_81","first-page":"1935","article-title":"Supplementation of garlic and coriander seed powder: Impact on body mass index, lipid profile and blood pressure of hyperlipidemic patients","volume":"31","author":"Zeb","year":"2018","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"102282","DOI":"10.1016\/j.ctim.2019.102282","article-title":"Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study","volume":"48","author":"Iskandar","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7897\/2277-4343.083194","article-title":"Efficacy and safety study of triphala in patients of dyslipidemia: A pilot project","volume":"8","author":"Kuchewar","year":"2017","journal-title":"Int. J. Res. Ayurveda Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0253-7613.93857","article-title":"A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin","volume":"44","author":"Bhatt","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Upadya, H., Prabhu, S., Prasad, A., Subramanian, D., Gupta, S., and Goel, A. (2019). A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-019-2430-y"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/546\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:09:50Z","timestamp":1760162990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":85,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["medicina57060546"],"URL":"https:\/\/doi.org\/10.3390\/medicina57060546","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]}}}